REG - Directa Plus PLC - Notice of Results

Directa PlusAnnouncement

13/09/2024 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240913:nRSM9643Da&default-theme=true

RNS Number : 9643D  Directa Plus PLC  13 September 2024

13 September 2024

Directa Plus plc

("Directa Plus", the "Group" or the "Company")

 

Notice of Results

 

Directa Plus (AIM: DCTA), a leading producer and supplier of graphene
nanoplatelets based products for use in consumer and industrial markets,
expects to announce its results for the six months ended 30 June 2024 on
Wednesday, 25 September 2024.

 

Analyst Presentation

 

Giulio Cesareo, CEO, and Giorgio Bonfanti, CFO, will host a live virtual
presentation and Q&A for analysts at 10am BST on Wednesday, 25 September
2024.

 

To register to attend, please contact directaplus@almastrategic.com
(mailto:directaplus@almastrategic.com) .

 

Investor Presentation

 

Management will also host a live virtual presentation and Q&A for retail
investors at 12pm BST on Monday, 30 September 2024 via the Investor Meet
Company platform.

 

To register to attend, please do so here
https://www.investormeetcompany.com/directa-plus-plc/register-investor
(https://www.investormeetcompany.com/directa-plus-plc/register-investor)

 

 

For further information, please contact:

 

 Directa Plus plc                                                        +39 02 36714458
 Giulio Cesareo, CEO
 Giorgio Bonfanti, CFO

 Cavendish Capital Markets Limited (Nominated Adviser and Joint Broker)  +44 131 220 6939
 Neil McDonald
 Adam Rae

 Singer Capital Markets Securities Limited (Joint Broker)                +44 20 7496 3069
 Rick Thompson
 Phil Davies

 Alma Strategic Communications (Financial PR Adviser)                    +44 20 3405 0205
 Justine James                                                           directaplus@almastrategic.com
 Hannah Campbell
 Kinvara Verdon

 

 

Notes to Editors

 

Directa Plus (www.directa-plus.com) is one of the largest producers and
suppliers of graphene-based products for use in consumer and industrial
markets. The Company's graphene manufacturing capability uses proprietary
patented technology based on a plasma super expansion process. Starting from
natural graphite, each step of Directa Plus' production process - expansion,
exfoliation and drying - creates graphene-based materials and hybrid graphene
materials ready for a variety of uses and available in various forms such as
powder, liquid and paste.

 

This proprietary production process uses a physical process, rather than a
chemical process, to process graphite into pristine graphene nanoplatelets,
which enables Directa Plus to offer a sustainable, non-toxic product, without
unwanted by-products.

 

Directa Plus' products are made of hybrid graphene materials and graphene
nano-platelets. The products (marketed as G+(R)) have multiple applications
due to its properties. These G+(R) products can be categorised into various
families, with different products being suitable for specific practical
applications.

 

Directa Plus was established in 2005 and is based in Lomazzo (Como, Italy) and
has been listed on the AIM market of the London Stock Exchange since May 2016.
Directa Plus holds the Green Economy Mark from London Stock Exchange which
recognises companies that contribute to the global green economy.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NORSFWSUEELSELU